In the young male with high level of the NLRP3 inflammasome activity especially the IMIDs-chronic colitis patients, testosterone could modulate the NLRP3 inflammasome activity and promoting the NLRP3 inflammasome-related tumor genesis activity [37]. Here, NLRP3 is linked to neoplasm.